Tuesday, April 12th 2022 at 10 am EDT | 7 am PDT | 3 pm GMT
Freezing and thawing biotherapeutics requires experienced leadership to navigate material and instrument selection as well as quality, space, regulatory and other considerations in creating a new cold-chain ecosystem. This webinar discusses the design of processes in partnership with a uniquely resourced freeze/thaw technology center.
Implementing a few recommended guidelines increases visibility in your distribution lane, incorporates robust materials, and qualifies them against relevant metrics to ensure consistent product quality in the cold chain.
*Wednesday, May 19, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* The selection of single-use materials for novel gene therapies, as well as the material’s commercial viability, is crucial especially for those used in storage and cryogenic operations. Learn about key product contact material and process compatibility requirements during this webcast. *On Demand Until May 19, 2022*
Explore single-use bag system technologies for freeze/thaw applications in bulk drug substance (BDS) manufacturing. Transitioning to SUT can be an efficient, cost-effective option for biopharmaceutical manufacturers to hit performance targets.
High-density cell banking accelerates the upstream process by providing concentrated cells to jumpstart a production run. This intensification eliminates many laborious and risky steps used in most labs
A frozen shipping study conducted on single-use fluoropolymer bags following new guidelines that help to mitigate the risks during frozen shipping while ensuring consistent product quality in cold chain distribution.